Ancer Medical Inc. has developed two applicators with innovative design used in HDR (high-dose rate) brachytherapy treatments for cancers of the esophagus and rectum. The applicators were developed in collaboration with a world-renowned cancer research and treatment institution, using innovative balloon configurations to enable optimal positioning in multiple treatments. Both products are FDA 510(k) cleared and are the subject of pending and issued patents.
The E-App Esophageal Applicator features independently inflated balloons that form a consistent tubular shape, centering the radiation source for uniform dose delivery. The AR-App Ano-rectal Applicator uses a uniquely compliant design that creates tissue separation, delivering a very high dose to the tumor while sparing healthy tissue.
Contact: info@ancer.co.com